Characteristics and Risk Factors of Postoperative Complications in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
Despite the continuous development of medical devices and the standardization of gastrectomy plus D2 lymph node dissection, advanced gastric cancer still has high distant metastasis rate and local recurrence rate, and the prognosis is poor. Neoadjuvant chemotherapy can improve the long-term survival...
Guardado en:
Autores principales: | SUN Chongyuan, ZHAO Dongbing |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c4c108a45c94a409800d9abf2f3ea30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study
por: Hua Yang, et al.
Publicado: (2021) -
Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
por: Zhi Zhu, et al.
Publicado: (2020) -
Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
por: Nadezhda A. Brish, et al.
Publicado: (2021) -
Correlative Analysis Between Adverse Events of Preoperative Chemotherapy and Postoperative Complications of Gastric Cancer
por: Zhouqiao Wu, et al.
Publicado: (2021) -
Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
por: Ziyi Liu, et al.
Publicado: (2021)